KTTA vs AMGN: Which Stock is Better?
Side-by-side comparison of Pasithea Therapeutics Corp and Amgen Inc in 2026
KTTA
Pasithea Therapeutics Corp
$0.74
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | KTTA | AMGN | Winner |
|---|---|---|---|
| Market Cap | $18.36M | $191.53B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.46 | AMGN |
| Revenue Growth | 15.0% | 0.1% | KTTA |
| Gross Margin | -0.5% | 70.8% | AMGN |
Analyze KTTA
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KTTA or AMGN a better investment?
Comparing KTTA and AMGN: Pasithea Therapeutics Corp has a market cap of $18.36M while Amgen Inc has $191.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KTTA and AMGN?
KTTA (Pasithea Therapeutics Corp) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KTTA or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KTTA or AMGN?
KTTA has higher revenue growth at 15.0% vs 0.1% for AMGN.
Which company is more profitable: KTTA or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -0.5% for KTTA.
Which is the larger company: KTTA or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $191.53B compared to $18.36M for KTTA.
Should I buy KTTA or AMGN in 2026?
Both KTTA and AMGN have investment merit. KTTA trades at $0.74 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KTTA and AMGN stock?
Key differences: Market Cap ($18.36M vs $191.53B), P/E Ratio (N/A vs 24.6x), Revenue Growth (15.0% vs 0.1%), Gross Margin (-0.5% vs 70.8%).